Evidence map›Paper›PMID 40487764›Full record

ArticleFrontiers in endocrinology2025

Risk factors associated with low bone mineral density and childhood osteoporosis in a population undergoing skeletal growth: a cross-sectional analytic study.

Berta Magallares, Dacia Cerdá, Jocelyn Betancourt, Gloria Fraga, HyeSang Park, Helena Codes-Méndez, Estefanía Quesada-Masachs, Mireia López-Corbeto, Montserrat Torrent, Ana Marín and 6 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Berta MagallaresDepartment of Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Dacia CerdáDepartment of Rheumatology, Hospital Sant Joan Despí Moisès Broggi, Barcelona, Spain.
Jocelyn BetancourtInstitut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.
Gloria FragaInstitut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.
HyeSang ParkDepartment of Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Helena Codes-MéndezDepartment of Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Estefanía Quesada-MasachsDepartment of Rheumatology, Universitari Dexeus-Grupo Quirón Salud Hospital, Barcelona, Spain.
Mireia López-CorbetoDepartment of Pediatric Rheumatology, Vall d'Hebrón Barcelona Hospital Campus, Barcelona, Spain.
Montserrat TorrentDepartment of Pediatrics, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Ana MarínDepartment of Mineral Metabolism Unit - Internal Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Silvia HerreraInstitut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.
Ignasi GichInstitut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.
Susana BoronatInstitut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.
Jordi CasademontInstitut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.
Héctor CorominasDepartment of Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Jorge MaloufDepartment of Mineral Metabolism Unit - Internal Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Early identification of risk factors for low bone mass for chronological age (LBMca) and childhood osteoporosis (cOP) in patients undergoing skeletal growth is essential to mitigate long-term skeletal complications. cOP is diagnosed when LBMca (BMD Z-score ≤2) is accompanied by a clinically significant fracture history, or when vertebral fragility fractures are present. Methods: Patients under 21 years of age with at least one risk factor for LBMca (malabsorption syndrome, chronic inflammatory diseases, hematological diseases, endocrinopathies, drugs that affect bone metabolism, or insufficient calcium intake) were included. Data on fractures history and physical activity levels were collected. Spine and whole-body dual-energy x-ray absorptiometry (DXA) and vertebral morphometry were performed. Age-adjusted linear regression analysis evaluated associations between bone mineral density (BMD) and risk factors. Results: A total of 103 patients were included (mean age 9.8 years; 52.4% female), and 96.1% had more than two risk factors. The prevalence of LBMca was 10.5% and the prevalence of cOP was 4.8%. Vertebral BMD was positively associated with male sex. Whole body BMD was negatively associated with sedentary lifestyle and fracture history. Total body less head BMD showed negative associations with current steroid treatment, sedentary lifestyle, and history of fractures. Conclusions: Pediatric populations at risk of LBMca or cOP often have multiple risk factors, notably modifying ones such as physical inactivity. Up to 10.5% of children with risk factors present LBMca and 4.8% have an undiagnosed or unknown cOP. Longitudinal studies are warranted to understand the long-term impact of the identified risk factors, including age, sex, sedentary lifestyle, ethnicity and vitamin D status, on bone health.

Indexed as

Bone DensityBone DevelopmentOsteoporosisAbsorptiometry, PhotonAdolescentChildChild, PreschoolCross-Sectional StudiesFemaleHumansMaleRisk FactorsYoung Adultbone fragilitybone mineral densitychildhood osteoporosisDXA (dual-energy x-ray absorptiometry)low bone mass for chronological age

Identifiers

PMID40487764
PMCPMC12141024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.